143 related articles for article (PubMed ID: 26065354)
21. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface.
Semeraro F; Forbice E; Nascimbeni G; Taglietti M; Romano V; Guerra G; Costagliola C
In Vivo; 2016 11-12; 30(6):931-938. PubMed ID: 27815483
[TBL] [Abstract][Full Text] [Related]
22. Pilocarpine toxicity and the treatment of xerostomia.
Hendrickson RG; Morocco AP; Greenberg MI
J Emerg Med; 2004 May; 26(4):429-32. PubMed ID: 15093850
[TBL] [Abstract][Full Text] [Related]
23. Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye.
Berra M; Galperín G; Berra F; Marquez MI; Mandaradoni M; Tau J; Berra A
Arq Bras Oftalmol; 2021; 85(2):103-108. PubMed ID: 34431892
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.
Devecı H; Kobak S
Int Ophthalmol; 2014 Oct; 34(5):1043-8. PubMed ID: 24442759
[TBL] [Abstract][Full Text] [Related]
25. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
26. Corneal epithelial permeability and dry eye treatment.
Benitez-del-Castillo JM; Aranguez C; Garcia-Sanchez J
Adv Exp Med Biol; 2002; 506(Pt A):703-6. PubMed ID: 12613980
[No Abstract] [Full Text] [Related]
27. Comparison of autologous serum eye drops with different diluents.
Cho YK; Huang W; Kim GY; Lim BS
Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjögren's Syndrome.
Fang W; Qingqing Z; Qihui L; Bing Z; Xinyue H; Jie X
Altern Ther Health Med; 2023 Nov; 29(8):656-662. PubMed ID: 37678871
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren's Syndrome Dry Eye.
Kang MJ; Kim YH; Chou M; Hwang J; Cheon EJ; Lee HJ; Chung SH
Ocul Immunol Inflamm; 2020 Apr; 28(3):370-378. PubMed ID: 30986119
[No Abstract] [Full Text] [Related]
30. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome.
Toda I; Shinozaki N; Tsubota K
Cornea; 1996 Mar; 15(2):120-8. PubMed ID: 8925658
[TBL] [Abstract][Full Text] [Related]
31. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
32. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Thermal Pulsation Treatment for Dry Eye Syndrome in Patients With Sjogren Disease.
Godin MR; Stinnett SS; Gupta PK
Cornea; 2018 Sep; 37(9):1155-1158. PubMed ID: 29708939
[TBL] [Abstract][Full Text] [Related]
34. Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience.
Wander AH
Eye Contact Lens; 2011 Jan; 37(1):39-44. PubMed ID: 21178699
[TBL] [Abstract][Full Text] [Related]
35. The Association of Serum Vitamin D Level With the Severity of Dry Eye Parameters in Primary Sjögren Syndrome.
Lee JH; Kim SJ; Byun YS; Lee J; Park SH; Chung SH
Cornea; 2020 Jun; 39(6):702-705. PubMed ID: 31868853
[TBL] [Abstract][Full Text] [Related]
36. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
[TBL] [Abstract][Full Text] [Related]
37. Management of ocular surface inflammation in Sjögren syndrome.
Hyon JY; Lee YJ; Yun PY
Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
[TBL] [Abstract][Full Text] [Related]
38. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
Baek J; Doh SH; Chung SK
Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
[TBL] [Abstract][Full Text] [Related]
39. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
[TBL] [Abstract][Full Text] [Related]
40. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
Matsuo T
Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
